23 employees
Cardiol Therapeutics develops innovative cannabidiol medicines for heart disease.
2017
$17M
from 4 investors over 4 rounds
Cardiol Therapeutics Inc. raised $17M on May 13, 2020
Investors: Echelon Wealth Partners, AlbaCore Capital Group, Raymond James and Canaccord Financial